MDCE Stock Overview
A development stage company, engages in opening and operating children’s integrated health and wellness centers in China. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Medical Care Technologies Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0015 |
52 Week High | US$0.0078 |
52 Week Low | US$0.0008 |
Beta | 0.29 |
11 Month Change | -25.00% |
3 Month Change | 15.38% |
1 Year Change | -25.00% |
33 Year Change | -87.70% |
5 Year Change | 1,400.00% |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
MDCE | US Healthcare | US Market | |
---|---|---|---|
7D | 0% | 4.1% | 2.0% |
1Y | -25.0% | 4.6% | 32.4% |
Return vs Industry: MDCE underperformed the US Healthcare industry which returned 4.9% over the past year.
Return vs Market: MDCE underperformed the US Market which returned 32.6% over the past year.
Price Volatility
MDCE volatility | |
---|---|
MDCE Average Weekly Movement | 45.3% |
Healthcare Industry Average Movement | 6.9% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.9% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MDCE's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: MDCE's weekly volatility has increased from 35% to 45% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | 1 | Marshall Perkins | www.medicaretechinc.com |
Medical Care Technologies Inc., a development stage company, engages in opening and operating children’s integrated health and wellness centers in China. The company sells and distributes pharmaceutical and nutraceutical products, and other merchandise, including over-the-counter medicines, herbal products, personal care products, and family care products. It serves retail pharmacies, pharmaceutical companies, hospitals, physicians’ office practices, and consumers; and industrial and food microbiology laboratories.
Medical Care Technologies Inc. Fundamentals Summary
MDCE fundamental statistics | |
---|---|
Market cap | US$4.30m |
Earnings (TTM) | -US$195.08k |
Revenue (TTM) | US$616.38k |
8.1x
P/S Ratio-25.4x
P/E RatioIs MDCE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MDCE income statement (TTM) | |
---|---|
Revenue | US$616.38k |
Cost of Revenue | US$512.16k |
Gross Profit | US$104.22k |
Other Expenses | US$299.30k |
Earnings | -US$195.08k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.000059 |
Gross Margin | 16.91% |
Net Profit Margin | -31.65% |
Debt/Equity Ratio | 2.5% |
How did MDCE perform over the long term?
See historical performance and comparison